Teachers Advisors’s Atara Biotherapeutics ATRA Stock Holding History

Teachers Advisors’s Portfolio ATRA Stock Details ATRA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	$4.12M	Buy	4,146 +633	+18%	+$588K	0.01%	1545
2018 Q4	$3.05M	Buy	3,513 +96	+3%	+$89.2K	﹤0.01%	1590
2018 Q3	$3.53M	Buy	3,417 +61	+2%	+$59.6K	﹤0.01%	1656
2018 Q2	$3.08M	Buy	3,356 +537	+19%	+$577K	﹤0.01%	1691
2018 Q1	$2.75M	Buy	2,819 +910	+48%	+$829K	﹤0.01%	1640
2017 Q4	$864K	Buy	1,909 +20	+1%	+$7.38K	﹤0.01%	2311
2017 Q3	$782K	Buy	1,889 +3	+0.2%	+$1.13K	﹤0.01%	2368
2017 Q2	$660K	Buy	1,886 +44	+2%	+$17K	﹤0.01%	2467
2017 Q1	$946K	Sell	1,842 -3,655	-66%	-$1.51M	﹤0.01%	2218
2016 Q4	$1.95M	Buy	5,497 +287	+6%	+$122K	﹤0.01%	1789
2016 Q3	$2.79M	Buy	5,210 +1,120	+27%	+$608K	﹤0.01%	1521
2016 Q2	$2.3M	Buy	4,090 +484	+13%	+$232K	﹤0.01%	1572
2016 Q1	$1.72M	Hold	3,606	–	–	﹤0.01%	1666
2015 Q4	$2.38M	Buy	3,606 +2,600	+258%	+$1.97M	﹤0.01%	1492
2015 Q3	$791K	Buy	1,006 +162	+19%	+$198K	﹤0.01%	2133
2015 Q2	$1.11M	Buy	844 +452	+115%	+$519K	﹤0.01%	2055
2015 Q1	$408K	Buy	392 +265	+209%	+$175K	﹤0.01%	2551
2014 Q4	$85K	Buy	+127	New	+$77.6K	﹤0.01%	3069

Other funds holding ATRA

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Baupost Group Boston, Massachusetts $5.12B AUM 15.99% 1-Year Est. Return

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

CCM

Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Bridger Management New York $128M AUM 9.54% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Teachers Advisors's ATRA Position: Q1 2019 in Review

Teachers Advisors increased its Atara Biotherapeutics (ATRA) stake by 18% in Q1 2019, buying an estimated $588K and bringing the position to 4,146 shares worth $4.12M. The position accounts for 0.01% of the portfolio, ranked #1545.

Teachers Advisors first reported a position in ATRA in Q4 2014 and has held it in 18 quarters since. 120 funds tracked by Wall St. Rank hold ATRA as of Q1 2019.

Teachers Advisors held 4,146 shares of Atara Biotherapeutics worth $4.12M as of Q1 2019.
Teachers Advisors bought 633 Atara Biotherapeutics shares in Q1 2019, an estimated $588K.
Atara Biotherapeutics made up 0.01% of Teachers Advisors's portfolio in Q1 2019, its #1545 holding.
Teachers Advisors first reported a position in Atara Biotherapeutics in Q4 2014 and has held it in 18 quarters since.
120 funds tracked by Wall St. Rank held Atara Biotherapeutics as of Q1 2019.

Based on Teachers Advisors's 13F filing for Q1 2019, filed 14 May 2019.